|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/02 | (2006.01) |
| (11) | Number of the document | 3284754 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17189925.5 |
| Date of filing the European patent application | 2011-12-30 | |
| (97) | Date of publication of the European application | 2018-02-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation | 2021-01-25 |
| (30) | Number | Date | Country code |
| 201061428699 P | 2010-12-30 | US | |
| 201161470406 P | 2011-03-31 | US | |
| 201161470382 P | 2011-03-31 | US | |
| 201161485104 P | 2011-05-11 | US |
| (72) |
ELIAS, Kathleen Ann, US
LANDES, Gregory, US
SINGH, Shweta, US
KORVER, Wouter, US
DRAKE, Andrew Walling, US
HAAK-FRENDSCHO, Mary, US
SNELL, Gyorgy Pal, US
BHASKAR, Vinay, US
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūnai prieš CD38 |
| ANTI-CD38 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 14 | 289.00 EUR |
| 2025-12-30 |